Flagship Harbor Advisors’s Insys Therapeutics, Inc. INSY Stock Holding History

Flagship Harbor Advisors’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-105	Closed	–	–	2036
2019 Q1	$0	Hold	105	–	–	﹤0.01%	2012
2018 Q4	$0	Hold	105	–	–	﹤0.01%	2201
2018 Q3	$1K	Hold	105	–	–	﹤0.01%	2054
2018 Q2	$0	Buy	+105	New	+$732	﹤0.01%	2110

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Flagship Harbor Advisors's INSY Position: Q2 2019 in Review

Flagship Harbor Advisors sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 105 shares.

Flagship Harbor Advisors first reported a position in INSY in Q2 2018 and held it in 4 quarters. The position peaked at $1K in Q3 2018. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Flagship Harbor Advisors reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Flagship Harbor Advisors sold 105 Insys Therapeutics, Inc. shares in Q2 2019.
Flagship Harbor Advisors first reported a position in Insys Therapeutics, Inc. in Q2 2018 and held it in 4 quarters.
Flagship Harbor Advisors's Insys Therapeutics, Inc. position peaked at $1K in Q3 2018.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Flagship Harbor Advisors's 13F filing for Q2 2019, filed 22 Jul 2019.